Navidea Biopharmaceuticals to Present at the JMP Securities Healthcare Conference

Published: Jul 09, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents, today announced that Dr. Mark Pykett, Navidea’s President and Chief Executive Officer, will participate at the JMP Securities Healthcare Conference on July 12-13, 2012 at the Peninsula Hotel in New York City. Dr. Pykett will provide an update of the Company and its development programs on Thursday, July 12, 2012 at 12:30 PM EDT.

Back to news